Back to Search Start Over

Flynetra, a Biosimilar to Neulasta, Now Available

Authors :
Park, Brian
Source :
MPR Monthly Prescribing Reference. May 17, 2023
Publication Year :
2023

Abstract

Fylnetra[sup.™] (pegfilgrastim-pbbk), a biosimilar to Neulasta[sup.®] (pegfilgrastim), has been made available by Amneal. The Food and Drug Administration (FDA) approved Fylnetra, a leukocyte growth factor, based on data demonstrating a [...]

Subjects

Subjects :
United States. Food and Drug Administration
Drug approval
Health
Fylnetra (Medication)
Neulasta (Medication)

Details

Language :
English
ISSN :
08830266
Database :
Gale General OneFile
Journal :
MPR Monthly Prescribing Reference
Publication Type :
Periodical
Accession number :
edsgcl.749593174

Tools

Authors Abstract Subjects Details